Scleroderma Clinical Trials
PeerBasis did not identify a benchmark-executive compensation figure for Scleroderma Clinical Trials in its current latest-filed snapshot; this does not mean the organization reported no executive compensation.
Review the available peer set
Peer data are available for Scleroderma Clinical Trials. Open the preview and enter the 2025-dollar compensation amount the board is evaluating before preparing a report.
Open the previewSelected peer organizations
Actual selection tier: Same NTEE sector (H99), nationwide + size band 0.67–1.5× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Hawaii Cellular Therapy And Transplant | HI | $323,338 | $80,728 |
| Heme Foundation | PA | $342,296 | $149,089 |
| The Ros1ders Inc | CA | $350,739 | $19,802 |
| Alaska Cardiovascular Research | AK | $351,598 | $68,559 |
| International Biomedical Research | DC | $292,601 | $138,323 |
| Salisbury Foundation For Research And Education Inc | NC | $380,895 | $54,573 |
| Humanology & Health Science Inc | CA | $264,216 | $147,133 |
| American Sleep Apnea Association Inc | DC | $390,961 | $142,901 |
View the organization record and available filings on ProPublica